UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 14, 2012

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

___________________

Delaware	1-07151	31-0595760
(State or other jurisdiction of	(Commission File Number)	(I.R.S. Employer
incorporation)		Identification No.)

1221 Broadway, Oakland, California  94612-1888
(Address of principal executive offices)   (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

---

Item 5.07 Submission of Matters to a Vote of Security Holders.

     On November 14, 2012, The Clorox Company (the “Company”) held its annual meeting of stockholders in Pleasanton, California. The matters voted on and the results of the vote were as follows:

1.

The Company’s stockholders re-elected the following directors to each serve until the next Annual Meeting of Stockholders or until a successor is duly elected and qualified.

		Number of Votes
		For		Against		Abstain		Broker Non-Votes
Daniel Boggan, Jr.		85,253,336		750,213		413,292		26,213,025
Dr. Richard H. Carmona		83,859,628		2,156,176		401,036		26,213,025
Tully M. Friedman		83,897,752		2,127,498		391,591		26,213,025
George J. Harad		84,261,758		1,759,865		394,813		26,213,025
Donald R. Knauss		83,737,863		2,274,999		403,574		26,213,025
Robert W. Matschullat		83,933,382		2,092,313		390,741		26,213,025
Edward A. Mueller		85,340,080		689,067		387,694		26,213,025
Pamela Thomas-Graham		85,698,865		335,403		382,573		26,213,025
Carolyn M. Ticknor		85,468,882		566,460		381,499		26,213,025

2.

The Company’s stockholders voted for (on an advisory basis) the compensation of the Company’s named executive officers.

3.

The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2013.

4.

The Company’s stockholders voted for the approval of the amended and restated 2005 stock incentive plan.

---

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		THE CLOROX COMPANY
Date:     November 16, 2012		By:		/s/ Laura Stein
				Senior Vice President –
				General Counsel

---